Journal of Cancer Research and Therapeutics

REVIEW ARTICLE
Year
: 2019  |  Volume : 15  |  Issue : 4  |  Page : 751--754

Interpretation of adverse reactions and complications in Chinese expert consensus of Iodine-125 brachytherapy for pancreatic cancer


Qingchun Li1, Yun Liang2, Ye Zhao1, Baodong Gai1 
1 Department of Gastrointestinal Surgical, Third Hospital of Jilin University, Changchun, China
2 Department of Physical Examination, Third Hospital of Jilin University, Changchun, China

Correspondence Address:
Baodong Gai
Department of Gastrointestinal Surgical, Third Hospital of Jilin University, 126 Xiantai St, Changchun 130031
China

Owing to the location of the pancreas and its complex anatomical relationship, it is difficult to perform radioactive Iodine-125 seed implantation in patients with pancreatic cancer as it can cause surgical side effects and further complications. To standardize the procedure of radioactive Iodine-125 seed implantation in the treatment of pancreatic cancer and reduce the occurrence of adverse reactions and complications during and after operation, the Chinese Medical Doctor Association of Radioactive Seed Implantation Technology Expert Committee, Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association, and the Radioactive Seed Therapy Branch organized and helped establish an expert consensus in China regarding radioactive Iodine-125 seed implantation in the treatment of pancreatic cancer. This article aims at interpreting the adverse reactions and complications after the implantation of radioactive seeds.


How to cite this article:
Li Q, Liang Y, Zhao Y, Gai B. Interpretation of adverse reactions and complications in Chinese expert consensus of Iodine-125 brachytherapy for pancreatic cancer.J Can Res Ther 2019;15:751-754


How to cite this URL:
Li Q, Liang Y, Zhao Y, Gai B. Interpretation of adverse reactions and complications in Chinese expert consensus of Iodine-125 brachytherapy for pancreatic cancer. J Can Res Ther [serial online] 2019 [cited 2019 Sep 22 ];15:751-754
Available from: http://www.cancerjournal.net/article.asp?issn=0973-1482;year=2019;volume=15;issue=4;spage=751;epage=754;aulast=Li;type=0